Table 1.

Demographics and Medication Use among 71 Patients with Juvenile Idiopathic Arthritis

Characteristic	Value
Female sex	42 (49%)
Age at diagnosis in years, mean (±SD)	8.2 (±5.3)
Length of follow-up in years, mean (±SD)	8.5 (±5.8)
JIA Subtype
Oligoarticular	45 (63%)
Polyarthritis	9 (12%)
Systemic	2 (3%)
Psoriatic arthritis	2 (3%)
Enthesitis related arthritis	1 (1%)
Unclassified	12 (17%)
Medications
NSAID	71 (100%)
Methotrexate	25 (35%)
Sulfasalazine	6 (8%)
Hydroxychloroquine	7 (10%)
Any DMARD	26 (37%)
TNF inhibitor	9 (13%)
IL-1 inhibitor	1 (1%)
Any Biologic	9 (13%)
Systemic Corticosteroids	19 (27%)
Any DMARD or Biologic	26 (37%)
Any DMARD, Biologic, or Systemic Corticosteroids	32 (45%)
Intraarticular Corticosteroid Injection	34 (48%)

Values in table are n (%) unless otherwise specified.

DMARD=Disease Modifying Antirheumatic Drug, JIA=Juvenile idiopathic arthritis, NSAID=Nonsteroidal anti-inflammatory drug